IL2 and neoplasm: However, recent preclinical studies have shown that other gamma-chain cytokines (such as IL-7 and IL-15) promote a less-differentiated T cell phenotype, resulting in longer persistence and better anti-tumor effects in comparison to IL-2 [12].